Chemoinformaics analysis of 5-PENTYLOXOLAN-2-ONE
| Molecular Weight | 156.225 | nRot | 4 |
| Heavy Atom Molecular Weight | 140.097 | nRig | 30 |
| Exact Molecular Weight | 156.115 | nRing | 1 |
| Solubility: LogS | -8.076 | nHRing | 1 |
| Solubility: LogP | 4.514 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 27 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 9 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 27.3027 |
| nHD | 0 | BPOL | 18.6553 |
| QED | 0.457 |
| Synth | 2.663 |
| Natural Product Likeliness | 0.69 |
| NR-PPAR-gamma | 0.05 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.009 |
| Pgp-sub | 0.001 |
| HIA | 0.002 |
| CACO-2 | -4.898 |
| MDCK | 0.0000719 |
| BBB | 0.28 |
| PPB | 0.920904 |
| VDSS | 0.528 |
| FU | 0.00939244 |
| CYP1A2-inh | 0.981 |
| CYP1A2-sub | 0.172 |
| CYP2c19-inh | 0.964 |
| CYP2c19-sub | 0.187 |
| CYP2c9-inh | 0.697 |
| CYP2c9-sub | 0.929 |
| CYP2d6-inh | 0.899 |
| CYP2d6-sub | 0.933 |
| CYP3a4-inh | 0.932 |
| CYP3a4-sub | 0.089 |
| CL | 13.199 |
| T12 | 0.111 |
| hERG | 0.045 |
| Ames | 0.93 |
| ROA | 0.042 |
| SkinSen | 0.845 |
| Carcinogencity | 0.958 |
| EI | 0.795 |
| Respiratory | 0.678 |
| NR-Aromatase | 0.09 |
| Antiviral | No |
| Prediction | 0.931437 |